Showing 1 - 10 of 11
This study focused on two primary areas: 1. To determine what can be learned from biotech and drug development companies that suffered from financial problems and ultimately failed at the beginning of the 21st century. 2. To determine how intellectual capital developed in accordance with such...
Persistent link: https://www.econbiz.de/10010987109
This paper compares the post-investment value-added activities performed by governmental venture capital (GVC) and independent venture capital (IVC) for their portfolio companies, and controls for the selection effect that the different investment profiles of these investors might have on the...
Persistent link: https://www.econbiz.de/10009278182
The paper reports an empirical study on the overall importance and non-financial value-added provided by Venture Capital (VC) investors to their investee firms in biotechnology. The study compares the characteristics of firms that have obtained VC funding with those of firms that have not....
Persistent link: https://www.econbiz.de/10005818355
This study focuses on the non-financial value-added Venture Capital (VC) investors bring to their portfolio companies, especially when these represent early-stage, high-technology and high-growth companies. The study draws attention to the extent and nature of non-financial value-added and...
Persistent link: https://www.econbiz.de/10005818377
Various approaches have been considered in Finland to catalyze new growth oriented innovative companies and to develop the functioning of the risk capital market. One approach suggested in several studies and public statements has been to consider creating tax incentives to catalyze informal...
Persistent link: https://www.econbiz.de/10005818442
The paper reports an empirical study on the non-financial value-added provided by Venture Capital investors to their investee firms. This study will use a four-class grouping of the various non-financial value-adding capabilities provided by VC firms, namely, scouting, monitoring, signalling and...
Persistent link: https://www.econbiz.de/10005749373
This study focuses on the non-financial value-added of venture capital investors (VCs) as perceived by the CEOs of Finnish biotechnology companies. It pays attention to differences in the value-added between informal venture capitalists, private sector venture capitalists and public sector...
Persistent link: https://www.econbiz.de/10005700280
This report is a descriptive account of the major features of the Venture Capital (VC) Industry in Finland. It has been prepared as a background report for a project entitled Venture Fun, carried out in an EU Network of Excellence PRIME and funded from the Sixth Framework Programme. The report...
Persistent link: https://www.econbiz.de/10005700316
This paper examines the knowhow in strategic business areas that venture capital companies and organizations impart to their portfolio firms in early-stage high-tech enterprises and the mechanisms they use to impart this knowledge. The paper considers three types of investors, independent,...
Persistent link: https://www.econbiz.de/10005700337
The paper summarizes the findings obtained during the first year of the Venture Fun project, carried out in an EU Network of Excellence PRIME and funded from the Sixth Framework Programme. The paper defines the central concepts of the project, identifies questions for further elaboration and...
Persistent link: https://www.econbiz.de/10005700419